276 related articles for article (PubMed ID: 10440088)
1. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
Chen YL; Shepherd C; Spinelli W; Lai FM
Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
[TBL] [Abstract][Full Text] [Related]
2. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
Stam WB; Van der Graaf PH; Saxena PR
Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
[TBL] [Abstract][Full Text] [Related]
3. Effects of the vasopressin V1a receptor antagonist, SR 49059, on the response of human uterine arteries to vasopressin and other vasoactive substances.
Kostrzewska A; Laudanski T; Steinwall M; Bossmar T; Serradeil-Le Gal C; Akerlund M
Acta Obstet Gynecol Scand; 1998 Jan; 77(1):3-7. PubMed ID: 9492709
[TBL] [Abstract][Full Text] [Related]
4. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA
Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
[TBL] [Abstract][Full Text] [Related]
5. Vascular effects of [Arg8]vasopressin in the isolated perfused rat kidney.
Barthelmebs M; Krieger JP; Grima M; Nisato D; Imbs JL
Eur J Pharmacol; 1996 Oct; 314(3):325-32. PubMed ID: 8957254
[TBL] [Abstract][Full Text] [Related]
6. The role of oxytocin receptors and vasopressin V1a receptors in uterine contractions in rats: implications for tocolytic therapy with oxytocin antagonists.
Chan WY; Wo NC; Manning M
Am J Obstet Gynecol; 1996 Nov; 175(5):1331-5. PubMed ID: 8942510
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue.
Anouar A; Clerget MS; Durroux T; Barberis C; Germain G
Eur J Pharmacol; 1996 Jul; 308(1):87-96. PubMed ID: 8836636
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery.
Calò G; Rizzi A; Traina L; Regoli D
Life Sci; 1997; 60(4-5):PL63-8. PubMed ID: 9010490
[TBL] [Abstract][Full Text] [Related]
9. Evidence for an involvement of vasopressin in mechanism of primary dysmenorrhea and effect of the non-peptide vasopressin V1a receptor antagonist, SR 49059, on the uterus of non-pregnant women.
Akerlund M; Bossmar T; Brouard R; Steinwall M
Adv Exp Med Biol; 1998; 449():467-72. PubMed ID: 10026840
[No Abstract] [Full Text] [Related]
10. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban.
Manning M; Miteva K; Pancheva S; Stoev S; Wo NC; Chan WY
Int J Pept Protein Res; 1995; 46(3-4):244-52. PubMed ID: 8537178
[TBL] [Abstract][Full Text] [Related]
12. High concentrations of oxytocin cause vasoconstriction by activating vasopressin V1A receptors in the isolated perfused rat kidney.
Loichot C; Krieger JP; De Jong W; Nisato D; Imbs JL; Barthelmebs M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):369-75. PubMed ID: 11330329
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibitory effect of SR 49059, an orally active non-peptide vasopressin VIa receptor antagonist, on human arterial coronary bypass graft.
Liu JJ; Chen JR; Buxton BB; Johnston CI; Burrell LM
Clin Sci (Lond); 1995 Nov; 89(5):481-5. PubMed ID: 8549062
[TBL] [Abstract][Full Text] [Related]
14. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.
Noguera I; Medina P; Segarra G; Martínez MC; Aldasoro M; Vila JM; Lluch S
Br J Pharmacol; 1997 Oct; 122(3):431-8. PubMed ID: 9351498
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro.
Wilson RJ; Allen MJ; Nandi M; Giles H; Thornton S
BJOG; 2001 Sep; 108(9):960-6. PubMed ID: 11563467
[TBL] [Abstract][Full Text] [Related]
16. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
Akerlund M; Melin P; Maggi M
Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
[TBL] [Abstract][Full Text] [Related]
17. Design of oxytocin antagonists, which are more selective than atosiban.
Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
[TBL] [Abstract][Full Text] [Related]
18. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
Serradeil-Le Gal C; Herbert JM; Delisee C; Schaeffer P; Raufaste D; Garcia C; Dol F; Marty E; Maffrand JP; Le Fur G
Am J Physiol; 1995 Jan; 268(1 Pt 2):H404-10. PubMed ID: 7840290
[TBL] [Abstract][Full Text] [Related]
19. Effect of pregnancy on vasopressin-mediated responses in guinea-pig uterine arteries with intact and denuded endothelium.
Jovanović A; Grbović L; Jovanović S; Zikić I
Eur J Pharmacol; 1995 Jul; 280(2):101-11. PubMed ID: 7589173
[TBL] [Abstract][Full Text] [Related]
20. Adaptation to pregnancy leads to attenuated rat uterine artery smooth muscle sensitivity to oxytocin.
Vedernikov YP; Betancourt A; Wentz MJ; Saade GR; Garfield RE
Am J Obstet Gynecol; 2006 Jan; 194(1):252-60. PubMed ID: 16389040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
